Annex III Entry 307 27/07/2020

HYDROLYZED WHEAT PROTEIN

Hydrolyzed wheat protein

HYDROLYZED WHEAT PROTEIN is listed in Annex III and may only be used under the conditions shown in this record.

Restricted substance— Annex III, EU Regulation 1223/2009
Entry: 307

Record details

Other restrictions

Maximum molecular weight average of the peptides in hydrolysates: 3,5 kDa (23 )

INCI glossary name

HYDROLYZED WHEAT PROTEIN

Chemical name

Hydrolyzed wheat protein

Chemical / IUPAC name

Hydrolyzed wheat protein

Regulatory information

Regulation

(EU) 2017/2228

Key data

Inventory links for HYDROLYZED WHEAT PROTEIN

Inventory Restriction reference
Ref 76681

HYDROLYZED WHEAT PROTEIN

CAS: 94350-06-8 / 222400-28-4 / 70084-87-6 / 100209- 50-5
EC: 305-225-0 / - / 309-358-5

Direct matches are limited for this record, so nearby entries from Annex III are shown as well.

Annex III 305
Nearby record in the same annex

BASIC BLUE 124

CAS: 67846-56-4
EC: 267-370-5
Annex III 304
Nearby record in the same annex

BASIC BROWN 17

CAS: 68391-32-2
EC: 269-944-0
Annex III 310
Nearby record in the same annex

CLIMBAZOLE

CAS: 38083-17-9;
EC: 253-775-4;
Annex III 312
Nearby record in the same annex

FURFURAL

CAS: 98-01-1
EC: 202-627-7
Annex III 313
Nearby record in the same annex

HEMA

CAS: 868-77-9
EC: 212-782-2

What Annex III means for HYDROLYZED WHEAT PROTEIN

HYDROLYZED WHEAT PROTEIN is a restricted substance under Annex III of EU Cosmetics Regulation 1223/2009. Its use in cosmetics is only permitted under the specific conditions set out in the entry above, including applicable concentration limits, product type restrictions and required warning statements.

When including this substance in a formulation, all conditions — maximum concentration, product scope and warning labels — must be met simultaneously. Compliance with one condition does not override the others.

This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

  • Document conditions of use in the Product Information File (PIF).

Frequently asked questions

HYDROLYZED WHEAT PROTEIN is listed in Annex III of EU Regulation 1223/2009 as a restricted substance. It may only be used under the conditions specified in the entry, including any maximum concentration, product type limitation and required warning statements shown above.

CAS 94350-06-8 / 222400-28-4 / 70084-87-6 / 100209- 50-5 is the unique numerical identifier assigned to HYDROLYZED WHEAT PROTEIN by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.

Source note for Annex III record HYDROLYZED WHEAT PROTEIN

This page summarizes one Annex III record for HYDROLYZED WHEAT PROTEIN from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex III conditions for HYDROLYZED WHEAT PROTEIN, but confirm any final regulatory decision against the current official annex wording and source files.

Tools & next steps

Check your formula

Paste a full INCI list to detect HYDROLYZED WHEAT PROTEIN and other flagged EU annex records in one pass.

INCI Checker

Compare entries

Compare HYDROLYZED WHEAT PROTEIN side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Compare

Browse the annex

See all records in Annex III and compare regulatory conditions across substances in this annex.

Open Annex III